Dural Repair Market Analysis | United States | 2017-2023 | MedCore

Dural Repair Market Analysis | United States | 2017-2023 | MedCore

0

The dura mater is a tough, fibrous membrane that surrounds and protects the tissues of the brain and spinal cord. Dural repair is primarily performed for head and spinal injuries where a laceration has occurred to the dura, and for neurosurgical procedures in which the dura is required to be opened or removed to gain access to the bones or delicate tissues within. In both cases, effective dural closure is imperative to prevent cerebrospinal fluid (CSF) leakage and permit proper and expeditious wound healing. Since CSF leaks often result in extra time and cost associated with patient care, dural repair performed with appropriate devices is integral for significant savings for surgeons and patients.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 526
  • Type: MedCore

Over the next few years, the xenograft segment will expand at the expense of the alloplast segment. The allograft segment will not change significantly in the near future. The vast majority of neurosurgeries are done on an in-patient basis due to the considerable degree of invasiveness required to perform the procedures, which further argues the case for the use of xenografts due to their reliability for dural repair applications.

The dura mater is a tough, fibrous membrane that surrounds and protects the tissues of the brain and spinal cord. Dural repair is primarily performed for head and spinal injuries where a laceration has occurred to the dura, and for neurosurgical procedures in which the dura is required to be opened or removed to gain access to the bones or delicate tissues within. In both cases, effective dural closure is imperative to prevent cerebrospinal fluid (CSF) leakage and permit proper and expeditious wound healing. Since CSF leaks often result in extra time and cost associated with patient care, dural repair performed with appropriate devices is integral for significant savings for surgeons and patients.

Segments Covered in This Market

  • Allograft Market
  • Xenograft Market
  • Alloplast Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Integra Lifesciences offers a line of dural repair products including the DuraGen® dural graft matrix, DuraGen Plus® dural regeneration matrix and the suturable DuraGen™ dural regeneration matrix. DePuy Synthes, a subsidiary of Johnson & Johnson, held a considerable share in the xenograft segment with DURAFORM™, a bovine-derived dura substitute. DURAFORM™ is made of a collagen-based biocompatible material that exhibits improved tensile strength and wet handling capabilities. Synovis/Baxter offers the Dura-Guard™ dural repair patch, a product derived from bovine pericardium, cross-linked with glutaraldehyde. Other companies analyzed include Stryker, W.L. Gore, Aesculap/B. Braun, Medtronic and Acelity.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Soft Tissue Reinforcement and Regeneration – MedSuite

Learn More about these product types



The "US Market Report Suite for Soft Tissue Reinforcement and Regeneration 2017 - MedSuite" includes analysis on the following companies currently active in this market:
LifeCell
Organogenesis
C.R. Bard
Ethicon
Covidien
Arthrex
ASTORA
Wright Medical
Integra LifeSciences
Smith & Nephew
MiMedx
Boston Scientific
Systagenix
BioHorizons
Atrium Medical
Coloplast
Stryker
Cook Medical
Johnson & Johnson
Osiris
Soluble Systems
Synovis/Baxter
KCI
RTI Biologics
Geistlich
TEI
Zimmer Biomet
ACell
Aesculap/B. Braun
Gore Medical
Medtronic
Dentsply
Others include: Medline, MTF, WL Gore, Tutogen, Novus Scientific, Ariste Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link